APPLICATIONS PUBLISHED 16 APRIL 2003
Published: 1-Oct-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Improved diagnostic method for detecting dysplastic epithelial tissue
Zila 1301164*
Melanin compsns
Zylepsis 1301165*
Storage-stable compsns of glycerol monoalkyl ethers
Air Liquide Sante International 1301168*
Preparation in the form of an emulsion that contains an oxygen carrier selected from haemoglobin and myoglobin, for use as a topically applicable cosmetic and for the natural regeneration of the skin in case of oxygen deficiency
SanguiBioTech 1301169*
Use and cosmetic comspsn of starch betainates
L'Oreal 1301170*
Use of extracted soluble protein fractions
Cognis France 1301171*
Low-vicsosity opacifiers without anionic surface-active agents
Cognis Deutschland 1301172*
A medicinal aerosol formulation
Aeropharm Technology 1301173*
Fast release bioadhesive microspheres for the sublingual administration of proximate principles
F. T. Holding 1301174*
Suppository and compsn comprising at least one polyethylene glycol
Aestic APS 1301175*
Method for coating solid particles with a thermofusible agent, and resulting coated solid particles
Gattefosse Holding 1301176*
Method and materials for controlling migration of binder liquid in a powder
Therics 1301177*
Delivery device
MW Encap 1301178*
Transdermal delivery system for highly dispersed silicon dioxide
Hexal 1301179*
Film dermatics
SCS Skin Care Systems 1301180*
Therapeutic and prophylactic use of recycled forms of pharmaceutical compounds
Hunter-Fleming 1301181*
Use of matrix metalloprotease inhibitors for the treatment of cancer
Simon, Christian 1301182*
Functionalised active-nucleus complex sensor
The Regents of the University of California 1301183*
Valproic acid and derivatives thereof as histone deacetylase inhibitors
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus 1301184*
Anthelminthic agents for the prevention of parasitic infections in humans and animals
Bayer 1301185*
Sildenafil citrate solid dispersions having high water solubility
Lavipharm Laboratories 1301186*
Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV
Novo Nordisk 1301187*
Anthelmintic agents for preventing parasitic infections in humans and animals III
Bayer 1301188*
Use of 2-methylene-19-nor-20(S)-(a), 25-dihydroxyvitamin D3 to increase bone strength
Wisconsin Alumni Research Foundation 1301189*
Pepsin inhibition by alginates
Reckitt Benckiser Healthcare (UK) 1301190*
Potent immunostimulants from microalgae
The University of Mississippi 1301191*
Use of polysulphonated cyclodextrins for treating osteoarthritis
Les Laboratoires Servier 1301192*
Process for preparing compsn comprising medicinal herb extract for preventing and curing arthritis and compsn thereof
Biodix 1301193*
Essential oil combination and therapeutic uses thereof
Giraud, Anne Marie Pierrette 1301194*
Pharmaceutical uses of fibulin-1
Schering 1301195*
Stimulation of bone growth with thrombin peptide derivatives
The Board of Regents, The University of Texas Systems 1301197*
Fusion protein for inhibition of lipoprotein secretion
Wisconsin Alumni Research Foundation 1301198*
Methods for therapy of neurodegenerative disease of the brain
The Regents of the University of California 1301199*
Peptide pharmaceutical formulations
Bionebraska 1301200*
Treatment of glycogen storage disease type II
Duke University 1301201*
Genetically-engineered MHC molecules
Gavish-Galilee Bio Applications 1301202*
Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol mann-oligosaccharide
The Malaghan Institute of Medical Research 1301203*
Immunological combinations for prophylaxis and therapy of Helicobacter pylori infection
Merieux OraVax 1301204*
High fidelity polymerases and uses thereof
Invitrogen 1301205*
Treatment of central nervous system diseases by antibodies against glatiramer acetate
Teva Pharmaceutical Industries 1301206*
Compsns for treating bacterial infections, comprising an oxazolidinone compound, sulbactam and an ampicillin
Pharmacia & Upjohn 1301207*
Vaccine
The Austin Research Institute; The University of Melbourne 1301208*
Hyaluronan as a cytotoxic agent, drug pre-sensitiser and chemo-sensitiser in the treatment of disease
Meditech Research 1301209*
Compsns containing therapeutically active components having advanced solubility
Allergan 1301210*
Pharmaceutically active compound
Norgine Europe 1301212*
